Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Today, there are medical treatments that can slow down the rate at which HIV weakens the immune system, but currently there is no cure for the disease. However, there are other treatments that can prevent or cure the conditions associated with AIDS except few rare case reports under research. Consult your doctor for more information regarding various drug therapies for the treatment of HIV/AIDS.
Both pre and post exposure prophylaxis, or disease prevention, are available for HIV.
Pre-exposure prophylaxis (PrEP) - If you have not yet been exposed to HIV but are at risk of exposure, you can be counseld for pre-exposure prophylaxis. PrEP is a new HIV prevention option for HIV-negative individuals to reduce their risk of HIV infection.
Post-exposure prophylaxis (PEP) - If you have been exposed to HIV then you should call to make an appointment at a health care facility so you can be counseled for post exposure prophylaxis (PEP).
True or false: Now that drugs are available to treat HIV infection, AIDS is not much of a threat for most Americans.
The answer is false. HIV/AIDS experts worry that too many people believe otherwise, and have become less careful about protecting themselves from HIV and other STIs.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.